TocilizumabV1, Main, Exploration, indexHead, AbsEn.i

Index : AbsEn.i

Les termes de plus forte occurence

3092	patients
2817	arthritis
2515	treatment
2427	tocilizumab
2367	disease
2347	rheumatoid
1741	clinical
1438	therapy
1352	anti
1310	study
1140	receptor
1135	interleukin
1102	inflammatory
1061	these
1027	associated
1005	cell
996	were
925	review
920	efficacy
889	therapeutic
880	response
877	may
870	antibody
836	patient
828	drugs
809	after
799	treated
797	but
789	factor
781	systemic
778	also
762	title
759	results
755	however
749	cells
738	diseases
721	activity
713	other
698	data
694	tnf
690	agents
687	new
674	studies
671	effects
666	role
655	biologic
652	safety
632	drug
623	including
608	therapies
604	case
591	most
588	well
583	immune
577	inflammation
564	development
559	tumor
559	biological
557	first
556	severe
555	necrosis
554	both
549	risk
540	high
535	chronic
534	levels
533	who
533	trials
527	sec
527	analysis
523	potential
512	effective
511	cytokine
510	increased
507	abstract
506	there
506	during
495	syndrome
491	all
487	report
483	methotrexate
481	monoclonal
481	effect
478	tcz
475	years
474	modifying
470	inhibitors
466	management
465	related
453	refractory
447	remission
447	idiopathic
447	autoimmune
445	current
437	year
437	significant
434	evidence
429	non
427	pathogenesis
425	than
422	rituximab
419	juvenile
418	early
418	compared
415	induced
414	important
413	rheumatic
413	cases
404	recent
399	biologics
398	adverse
397	human
392	specific
391	novel
387	long
386	protein
385	factors
378	reported
377	still
377	although
376	background
376	acute
373	cytokines
370	different
369	several
368	only
368	diagnosis
364	significantly
364	abatacept
362	serum
361	onset
361	joint
361	against
360	symptoms
356	term
356	showed
351	present
350	had
349	active
348	dose
346	due
343	target
343	inhibitor
341	antibodies
334	expression
333	life
332	controlled
331	infection
330	common
329	evaluate
322	outcomes
318	available
313	low
313	cancer
312	literature
311	treatments
311	par
311	further
310	targeting
310	phase
309	could
309	antirheumatic
307	will
306	while
306	system
306	shown
305	objective
304	events
303	activation
300	humanized
300	developed
297	mechanisms
295	arteritis
294	combination
293	improved
293	conventional
292	trial
292	therefore
292	aim
290	large
290	characterized
289	progression
288	over
288	observed
286	mediated
286	inhibition
285	should
284	months
284	administration
280	effectiveness
275	many
274	currently
272	various
272	practice
272	demonstrated
270	blockade
268	addition
267	responses
266	when
266	weeks
266	approved
265	function
264	control
263	without
263	those
263	signaling
261	found
261	findings
260	old
260	involved
260	infections
258	infliximab
255	rate
254	adult
254	adalimumab
252	strategies
252	provide
252	number
250	targeted
250	dmards
249	suggest
249	recently
249	multiple
247	through
247	randomized
247	improvement
245	time
244	whether
244	group
243	rare
242	etanercept
240	major
240	here
239	changes
238	understanding
238	type
237	impact
236	rheumatology
236	following
236	evaluated
234	three
231	higher
231	agent
230	key
228	vasculitis
227	options
226	tissue
226	production
226	approach
225	cohort
224	often
224	manifestations
224	future
224	damage
223	outcome
223	disorders
223	blood
223	assess
222	bone
221	antigen
217	disorder
216	reduced
216	possible
216	increase
214	level
214	italic
214	failure
213	treat
212	pathway
212	immunosuppressive
211	positive
211	identified
211	children
210	involvement
210	investigated
210	course
210	complications
209	remains
209	primary
208	under
208	despite
208	care
208	age
207	reactive
207	monotherapy
207	investigate
207	conditions
207	assessment
206	model
206	health
206	being
205	limited
205	because
204	pathways
204	considered
203	promising
203	known
202	research
201	line
201	experience
200	thus
200	methods
198	score
197	elevated
196	population
195	survival
193	systematic
193	giant
193	assessed
192	need
192	decreased
192	criteria
192	association
191	describe
190	single
190	better
189	within
189	successful
189	advances
187	gene
186	castleman
185	receiving
185	molecular
184	treating
184	targets
184	quality
183	strategy
183	serious
183	profile
183	evaluation
182	unknown
182	real
181	improve
181	especially
181	article
180	since
180	like
179	mechanism
179	covid
178	include
178	fever
178	conclusion
177	features
177	cause
177	baseline
176	joints
176	growth
176	established
176	corticosteroids
176	cardiovascular
175	respectively
175	moderate
173	aimed
172	rates
172	inadequate
172	before
171	mtx
171	mortality
171	intravenous
171	characteristics
170	determine
169	lung
169	alpha
168	total
168	might
168	complex
167	pro
167	jia
167	included
167	discuss
166	world
166	sclerosis
165	lower
165	introduction
165	follow
164	regarding
164	identify
163	prognosis
163	performed
163	each
162	week
162	small
162	secondary
162	even
161	skin
161	play
161	fri
160	underlying
159	markers
158	side
158	leading
156	versus
156	similar
155	received
154	vitro
154	knowledge
153	revealed
153	reports
152	thu
152	renal
152	oral
152	option
152	loss
152	every
151	overall
150	release
150	reduction
150	increasing
149	previously
149	needed
149	laboratory
149	critical
148	tumour
148	retrospective
148	glucocorticoids
148	furthermore
147	chimeric
146	very
146	standard
146	second
146	remain
146	published
146	previous
146	models
145	process
145	potentially
145	good
145	did
145	achieved
145	according
143	diagnostic
143	diagnosed
143	condition
143	any
142	approaches
141	pain
141	lupus
141	administered
140	presence
140	caused
140	benefit
140	alternative
139	particularly
139	das
139	comparison
139	anakinra
138	takayasu
138	result
138	rapid
138	peripheral
138	less
138	few
137	synovial
137	lead
137	incidence
137	highly
136	via
136	successfully
136	given
136	described
136	antagonist
135	presented
135	led
135	either
134	placebo
134	moreover
134	influence
134	four
134	focus
133	plays
133	observational
133	now
133	mainly
132	negative
132	medical
132	last
132	european
132	dependent
132	compare
132	central
132	action
131	show
130	soluble
130	regulatory
130	plasma
130	label
130	initial
130	develop
130	biomarkers
129	vascular
129	purpose
129	meta
129	genetic
128	whereas
128	useful
128	molecules
128	imaging
128	emerging
128	cost
128	blocking

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/Main/Exploration/AbsEn.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab - Exploration (Accueil) Index « AbsEn.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab - Exploration (Accueil)Index « AbsEn.i » - tête de navigation

Index : AbsEn.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « AbsEn.i » - tête de navigation